Anne Chevrel | Head of Discovery
Mabqi

Anne Chevrel joined Mabqi in 2023 as Head of Discovery, where she leads the design and development of innovative antibody-based therapeutics across internal and partnered programs. Her work integrates advanced AI-powered discovery platforms (combining Phage & Yeast displays) and enabling technologies to drive therapeutic innovation. Trained in protein engineering and biotechnology, she holds a PhD and brings over a decade of experience leading discovery and early development programs in biologics.